Role of supportive care for terminal stage hepatocellular carcinoma.
J Clin Exp Hepatol
; 4(Suppl 3): S130-9, 2014 Aug.
Article
en En
| MEDLINE
| ID: mdl-25755605
ABSTRACT
Patients with end stage or terminal HCC are those presenting with tumors leading to a very poor Performance Status (ECOG 3-4) or Child-Pugh C patients with tumors beyond the transplantation threshold. Among HCC patients, 15-20% present with end stage or terminal stage HCC. Their median survival is less than 3-4 months. The management of end stage or terminal HCC is only symptomatic and no definitive tumor directed treatment is indicated. Patients with end stage or terminal HCC should receive palliative support including management of pain, nutrition and psychological support. In general, they should not be considered for participating in clinical trials. This review focuses on palliative care of terminal stage HCC.
ACS, anorexia-cachexia syndrome; CBT, cognitive-behavioral therapy; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; QOL, quality of life; RT, radiotherapy; THC, tetrahydrocannabinol; WBRT, whole-brain radiation therapy; hepatitis B virus (HBV); hepatitis C (HCV); hepatocellular carcinoma (HCC)
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Aspecto:
Patient_preference
Idioma:
En
Revista:
J Clin Exp Hepatol
Año:
2014
Tipo del documento:
Article
País de afiliación:
India